AbCellera Biologics Inc.
ABCL
Rangering i aksjer
#4181
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Aksjekurs
$11.83
Markedsverdi
$3.83B
Endring (1 dag)
-0.88%
Endring (1 år)
101.79%
Land
CA
Handel AbCellera Biologics Inc. (ABCL)
Kategori
Healthcare
Historikk for aksjesplitt for AbCellera Biologics Inc. (ABCL)
Aksjen AbCellera Biologics Inc. (symbol: ABCL) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én ABCL-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 ABCL-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én ABCL-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 ABCL-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
